Monoclonal proteins after stem cell transplant may predict survival

08/26/2013 | MyelomaBeacon.com

Multiple myeloma patients whose monoclonal protein levels were declining 100 days after autologous stem cell trans­planta­tion survived longer overall and without disease progression, Mayo Clinic researchers found. The presence of lgG-type M proteins and myeloma cell levels of 3% or lower were linked with future continued response, according to the retrospective analysis in the journal Blood.

View Full Article in:

MyelomaBeacon.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI